Breaking
Monday, July 6, 2026

News

🇺🇸 FDA Page 6

Latest pharmaceutical news, drug approvals, and FDA regulatory updates

Showing 61–72 of 807 articles

Critical impact NewsJun 7, 2026

Danuglipron Phase 3 Watch After Pfizer’s Phase 2b Obesity Win

obesity · 6 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Biogen and Eisai expand Leqembi access with subcutaneous maintenance dosing

Alzheimer's disease · 5 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

FDA approves Vyloy for HER2-negative gastric and GEJ cancer

FDA · HER2-negative gastric cancer · 5 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Novo Nordisk supply of Wegovy stabilizes as FDA shortage ends

FDA · weight-loss · 5 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

J&J reports positive Phase 3 Tremfya data in ulcerative colitis

CHMP · ulcerative colitis · 7 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

Sanofi completes Inhibrx acquisition for $1.7B

inflammation · 4 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

MariTide Phase 2: Amgen reports up to 20% weight loss at one year

obesity · 5 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

FDA approves Dupixent for COPD with eosinophilic phenotype

FDA · chronic obstructive pulmonary disease · 6 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

GSK Blenrep wins FDA approval in relapsed multiple myeloma

FDA · blood cancer · 6 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Merck’s Harpoon acquisition deepens oncology pipeline ahead of Keytruda risk

oncology · 5 min

Dr. Sarah Mitchell
Critical impact NewsJun 7, 2026

Pfizer's Danuglipron Hits Phase 2b Obesity Endpoint

obesity · 7 min

Dr. Sarah Mitchell
High impact NewsJun 7, 2026

Roche reports positive Phase 3 results for trontinemab in Alzheimer's disease

EMA · Alzheimer's disease · 5 min

Dr. Sarah Mitchell